In-Vitro Effect of Modified Taohe Chengqi Decoction and Its Separated Prescriptions on Diabetic Angiopathy
- VernacularTitle:加味桃核承气汤及其拆方对糖尿病血管病变的体外作用观察
- Author:
Saimei LI
;
Jiajie LING
;
Zhigao WANG
- Publication Type:Journal Article
- Keywords:
DIABETES MELLITUS/TCD therapy;
MODIFIED TAOHE CHENGQI DECOCTION/pharmacology;
COMPATIBILITY(TCD);
CELL CULTURE;
SERUM PHARMACOLOGY
- From:
Journal of Guangzhou University of Traditional Chinese Medicine
2001;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of modified Taohe Chengqi Decoction(TCD)and its separated prescriptions on tissue plasminogen activator(tPA)and plasminogen activator inhibitor-1(PAI-1)content in human umbilical vein endothelial cells(HUVEC)with diabetic damage.Methods Purified HUVEC were divided into 10 groups: normal group,model group,rosiglitazone group,high-,middle-and low-dose modified TCD groups,blood-activating prescription group,heat-clearing and purgation prescription group,Qi-strengthening and yin-nourishing group,and TCD group.The serum containing herbal medicine was prepared through seropharmacological method,and was used for co-culture of HUVEC with high glucose and high insulin in vitro.The tPA and PAI contents in the HUVEC culture of different groups were detected.Results The content of tPA was increased in blood-activating prescription group and rosiglitazone group(P0.05).The PAI-1 content in the model group was higher than that in the normal group(P0.05).Conclusion The effect of modified TCD on improving the function of endothelial cells is probably related to the regulatory effect of blood-activating,heat-clearing and purgation herbs on PAI-1.
